Strategic Health Care Professional with More than
30+ Years of Experience:
Healthcare Strategy & Business Development
Supply Chain Management
Specialty Pharmacy
Managed Care/Pharmacy Benefit Management
Group Purchasing Organizations
Pharmacy and Medical Benefit Design
Drug Development and Commercialization
Clinical Pharmacy Practice
Strategic and highly accomplished C-suite healthcare executive with company start-up and program commercialization expertise in pharmaceutical industry, specialty pharmacy, Pharmacy Benefit Management (PBM), Group Purchasing Organizations (GPO), health plans/managed care pursuing an executive level role focusing on healthcare business strategy, execution, and innovation for established and start-up organizations.
2022 - Present
Create and execute upon short- and long-term strategic plans, implement new supply chain start up GPO model across the organization to drive affordability and access, and responsible for more than $17B in annual supply chain revenue.
As Chief Trade Relations Officer from 2022 to 2025, developed and executed company strategies for 7 departments at a start-up GPO. Oversaw contracting, pharmaceutical manufacturer relations, operations, and client relations, achieving over $1.5B+ in annual medical contract revenue.
Led the development and implementation of a plan for pharmacy rebates starting early 2026, projected to generate approximately $15B in annual rebate revenue.
Member of the Executive Leadership Team and the Board of Directors participant.
2019 - 2022
Managed 65 employees in pharmaceutical relations, client rebate activities, contracts, rebate strategy, invoicing, and Trade's tech initiatives.
Created and managed the MedDrive medical program for Blues plans and rebate aggregator clients that included $700M in medical rebates revenue annually.
Created, implemented, and managed GPO partnership with Ascent/Express Scripts for pharmacy rebates and responsible for $10B in pharmacy annual rebates.
Member of Senior Leadership Team and Executive Leadership Team participant.
2019 - 2022
Represented Prime Therapeutic’s minority ownership interest in Ascent Health Services GPO
Consulted on GPO growth opportunities and strategic direction and profitability
2017 - 2024
Owner/operator of a health care consulting company
Past clients include pharmaceutical manufacturers, specialty pharmacy providers, and payors/PBMs
2017 - 2019
Led team managing pharmaceutical contracts for specialty therapies, PBM network contracting, corporate contract management, data analytics, specialty strategy, and business development.
Created new strategic partnerships with external stakeholders and redefined specialty care delivery and management for patients, payors, prescribers, and pharmaceutical manufacturers.
Responsible for > $125M in annual EBITDA contribution and improved margin opportunities for specialty pharmacy payer and manufacturer contracts.
Member of Executive Leadership Team.
2011 - 2017
Led a team that manages all aspects of pharmaceutical manufacturer contracting for specialty therapies including rebates, fee-for-service arrangements, discounts, rebates, and other contracting opportunities.
Created value propositions for specialty formulary management, specialty plan design, and proactive client consultation.
Managed >$150M in EBITDA annually and improved margin opportunities for specialty contracts.
As a specialty health care subject-matter expert internally and externally, provided strategic vision and expertise on the current and future trends in specialty care.
Led data monetization with aggregators, value-based outcomes, specialty product distribution, and clinical outcomes collaboration.
2009 - 2011
Developed, executed, and project managed oncology programs
Analyzed drug pipelines and forecast market impact and share
Created and implemented programs to improve patient adherence to oncology therapies
Developed and maintained pharmaceutical manufacturer relationships
Consulted with payors on formulary management initiatives
2004 - 2009
Led global brand and professional strategies for Preclinical through Phase 3 drugs including brand strategy, key opinion leader development, advisory board management, clinical program development, and market research projects to support product commercialization
Primary point person for Research and Development planning to support global product commercialization including Phase 3 trial design and life cycle management studies
Aligned strategies and commercial activities with Medical Affairs, Research and Development, Managed Markets, Business Analytics, and Sales to support successful product commercialization and pull through
Managed medical education and grant activities for Oncology, Diabetes, Gastrointestinal Disease, and Cardiovascular franchises
Managed Medical Information services for Gastrointestinal Disease, Gout, and Oncology franchises
Strategic
Ideation
Individualization
Futuristic
Relator
Avid golfer
Spin enthusiast
Wine connoisseur
Culinary artist
Entrepreneur
Other experiences include academia, clinical research, supply chain and group purchasing, pharmacy practice management, and specialty pharmacy and managed care thought leadership
Doctor of Pharmacy
1991
General Clinical Pharmacy Practice Residency
1991 - 1992